Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-04-14 @ 7:23 AM
Study NCT ID:
NCT01715818
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2012-10-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Sponsor:
Hoffmann-La Roche
Organization: